CAS: 188589-32-4 - 1-DECYL-3-METHYLIMIDAZOLIUM BROMIDE
Formula:C14H27BrN2
InChI:InChI=1/C14H27N2.BrH/c1-3-4-5-6-7-8-9-10-11-16-13-12-15(2)14-16;/h12-14H,3-11H2,1-2H3;1H/q+1;/p-1
- Synonyms:
- 1-Decyl-3-methyl-1H-imidazol-3-ium bromide
- 1H-imidazolium, 1-decyl-3-methyl-, bromide (1:1)
- 1H-imidazolium, 3-decyl-1-methyl-, bromide (1:1)
- 3-decyl-1-methyl-1H-imidazol-3-ium bromide
- 1-Decyl-3-Methyl-Imidazol-3-Ium Bromide
- 1-Dodecyl-3-Methylimidazolium Bromide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1-Decyl-3-methylimidazolium Bromide REF: 3B-D5350CAS: 188589-32-4 | >98.0%(HPLC) | 80.00 €~224.00 € | Tue 03 Dec 24 | |
1H-Imidazolium, 3-decyl-1-methyl-, bromide (1:1) REF: IN-DA002H03CAS: 188589-32-4 | 98% | 47.00 €~570.00 € | Tue 10 Dec 24 | |
1-Decyl-3-methylimidazolium Bromide REF: 3D-NHA58932CAS: 188589-32-4 | Min. 95% | To inquire | Tue 21 Jan 25 | |
1-decyl-3-methylimidazolium bromide REF: 10-F544628CAS: 188589-32-4 | 98.0% | - - - | Discontinued product |
1-Decyl-3-methylimidazolium Bromide
CAS:188589-32-4
Formula:
C14H27BrN2
Purity:
>98.0%(HPLC)
Color and Shape:
Light yellow to Brown clear liquid
Molecular weight:
303.29
Ref: 3B-D5350
5g | 80.00 € | ||
25g | 224.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
1H-Imidazolium, 3-decyl-1-methyl-, bromide (1:1)
CAS:188589-32-4
Formula:
C14H29BrN2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
305.2975
Ref: IN-DA002H03
5g | 47.00 € | ||
25g | 96.00 € | ||
100g | 190.00 € | ||
500g | 570.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
1-Decyl-3-methylimidazolium Bromide
CAS:188589-32-4
1-Decyl-3-methylimidazolium Bromide is a cationic surfactant that has been shown to be an effective antimicrobial …
Formula:
C14H27BrN2
Purity:
Min. 95%
Molecular weight:
303.29 g/mol
Ref: 3D-NHA58932
100g | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 10-F544628
5g | Discontinued | Request information | |
25g | Discontinued | Request information | |
100g | Discontinued | Request information |